RxDoctor Payments Data

Rachel Southard

Adult Health · New Haven, CTNPI 1669809604

Payments from drug & device makers

$3,494in general payments, 2019–2025

Across 180 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$520
  • AbbVie$506
  • AstraZeneca$370
  • Lilly USA, LLC$300
  • Novo Nordisk$276
  • Boehringer Ingelheim$198
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,494100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,494 in reported general payments places this provider in the 80th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$14,134
Medicare patients
75
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$68,659
MounjaroTirzepatide20$29,000
JardianceEmpagliflozin16$27,174
FarxigaDapagliflozin Propanediol23$16,685
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,395
SynthroidLevothyroxine Sodium46$5,970
Lidocaine14$877
Levothyroxine Sodium64$871
Atorvastatin Calcium102$856
Azelastine Hcl17$682
Simvastatin52$500
Rosuvastatin Calcium48$499
Escitalopram Oxalate43$492
Metformin Hcl ErMetformin Hcl39$378
Gabapentin22$371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$276$68,65958 claims
Lilly USA, LLCMounjaro$300$29,00020 claims
Boehringer IngelheimJardiance$198$27,17416 claims
AstraZenecaFarxiga$370$16,68523 claims
GSKTrelegy Ellipta$520$8,39513 claims
AbbVieSynthroid$506$5,97046 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$29$87164 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 418 adult health providers in Connecticut.

Other adult health in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →